The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

Rapid Expansion in Market Size

The plasma fractionation market has witnessed robust growth, surging from $28.95 billion in 2023 to $31.78 billion in 2024, reflecting a commendable compound annual growth rate (CAGR) of 9.8%. This upward trajectory is fueled by several factors, including the rising prevalence of hemophilia and immunodeficiency disorders, an increasing aging population, growing demand for immunoglobulins, the expansion of plasma collection centers, and a surge in surgical procedures.

Anticipating Further Surge

The optimistic outlook continues into the forecast period, with the market poised to reach $46.72 billion in 2028 at a CAGR of 10.1%. This anticipated growth is attributed to the escalating global healthcare expenditure, expanding applications of plasma-derived medicinal products, heightened investments in research and development, the rising demand for plasma in treating neurological disorders, and the expansion of plasma fractionation facilities.

Key Trends in the Forecast Period

1. New Fractionation Technologies:The market is witnessing the development of innovative fractionation technologies.
2. Shift towards Albumin and Immunoglobulin Therapies:There is a noticeable trend towards therapies utilizing albumin and immunoglobulins.
3. Rising Demand for Specialty Plasma Products:Specialized plasma products are gaining traction, reflecting evolving patient needs.
4. Focus on Pathogen Inactivation Technologies:Ensuring safety through pathogen inactivation technologies is a priority.
5. Strategic Collaborations and Partnerships:Industry players are actively engaging in collaborations and partnerships, shaping the future of the plasma industry.

Elevated Demand Driven by Chronic Diseases

The increasing burden of chronic diseases is a significant driver for the heightened demand in the plasma fractionation market. As the number of individuals with chronic illnesses rises, reaching 142.66 million by 2050 in the United States alone, the demand for plasma products as a cost-effective and quality-improving treatment option is set to soar. Major players contributing to this growth include Baxter International Inc., CSL Limited, Grifols S. A, and many others.

View More On The Plasma Fractionation Market Report 2024 – https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Revolutionizing Through Technological Advancements

Technological advancements play a pivotal role in shaping the plasma fractionation market. Companies are introducing cutting-edge technologies such as HYCON, a fully automatic separator with self-cleaning capabilities. This not only improves hygienic conditions but also enhances cross-contamination prevention and batch safety. Such innovations contribute to the sustained growth and competitiveness of market participants.

Grifols’ Strategic Move Enhancing Global Presence

In April 2022, Grifols S. A. acquired Biotest AG for $317.03 million, a move aimed at revolutionizing plasma medicine availability. This strategic acquisition enables Grifols to expand its product line, own a vast network of plasma facilities, accelerate research and development projects, and achieve a more balanced revenue and supply distribution across geographies.

Market Segmentation Insights

1. By Product:The market is segmented into Immunoglobulins, Coagulation Factors, Albumin, and Protease Inhibitors.
2. By Application:Segments include Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, and Rheumatology.
3. By End User:The market caters to Hospitals and Clinics, Clinical Research Laboratories, and Academic Institutes.

Regional Dynamics

1. North America:Emerged as the largest region in 2023.
2. Asia-Pacific:Expected to be the fastest-growing region in the forecast period.

In conclusion, the plasma fractionation market is experiencing a transformative phase, marked by substantial growth, technological advancements, and strategic acquisitions. With the rise in chronic diseases, evolving therapies, and a focus on innovation, the market is poised for a promising future. Stakeholders, including major companies and investors, are actively shaping this dynamic landscape, anticipating a surge in demand and technological evolution in the coming years.

Request A Sample Of The Global Plasma Fractionation Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7543&type=smp